Fresenius Medical Care AG
XMUN:FME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fresenius Medical Care AG
XMUN:FME
|
DE |
|
Koninklijke Ahold Delhaize NV
AEX:AD
|
NL |
|
Realty Income Corp
NYSE:O
|
US |
|
C
|
CDL Hospitality Trusts
SGX:J85
|
SG |
|
A
|
Anglo American Platinum Ltd
JSE:AMS
|
ZA |
|
Leggett & Platt Inc
NYSE:LEG
|
US |
|
Koninklijke BAM Groep NV
AEX:BAMNB
|
NL |
|
Nikon Corp
TSE:7731
|
JP |
|
Shell PLC
LSE:SHEL
|
UK |
|
Dixon Technologies (India) Ltd
NSE:DIXON
|
IN |
Wall St Price Targets
FME Price Targets Summary
Fresenius Medical Care AG
According to Wall Street analysts, the average 1-year price target for FME is 45.42 EUR with a low forecast of 22.45 EUR and a high forecast of 65.23 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FME's stock price target?
Price Target
45.42
EUR
According to Wall Street analysts, the average 1-year price target for FME is 45.42 EUR with a low forecast of 22.45 EUR and a high forecast of 65.23 EUR.
What is the Revenue forecast for Fresenius Medical Care AG?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 3%.
What is the Operating Income forecast for Fresenius Medical Care AG?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 5 years is 10%.
What is the Net Income forecast for Fresenius Medical Care AG?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 5 years is 14%.
